{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:19:12Z","timestamp":1788873552437,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01511-4","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:02:11Z","timestamp":1780470131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiome\u2013blood cholesterol crosstalk: towards personalized strategies for dyslipidemia"],"prefix":"10.1007","author":[{"given":"Wirath Ben","family":"Ncir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Abdelhedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Ammar","family":"Keskes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"1","key":"1511_CR1","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1038\/s41467-026-70820-6","volume":"17","author":"G Arp","year":"2026","unstructured":"Arp G et al (2026) SpiR is a gut microbial enzyme that drives cholesterol conversion. Nat Commun 17(1):3495. https:\/\/doi.org\/10.1038\/s41467-026-70820-6","journal-title":"Nat Commun"},{"issue":"2","key":"1511_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1039\/C0MB00023J","volume":"7","author":"A-M Aura","year":"2010","unstructured":"Aura A-M et al (2010) Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro. Mol Biosyst 7(2):437\u2013446. https:\/\/doi.org\/10.1039\/C0MB00023J","journal-title":"Mol Biosyst"},{"issue":"4","key":"1511_CR3","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1039\/C8FO02594K","volume":"10","author":"D Beltr\u00e1n","year":"2019","unstructured":"Beltr\u00e1n D et al (2019) Re-examining the role of the gut microbiota in the conversion of the lipid-lowering statin monacolin K (lovastatin) into its active \u03b2-hydroxy acid metabolite. Food Funct 10(4):1787\u20131791. https:\/\/doi.org\/10.1039\/C8FO02594K","journal-title":"Food Funct"},{"issue":"44","key":"1511_CR4","doi-asserted-by":"publisher","first-page":"18933","DOI":"10.1073\/pnas.1007028107","volume":"107","author":"AK Benson","year":"2010","unstructured":"Benson AK et al (2010) Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc Natl Acad Sci U S A 107(44):18933\u201318938. https:\/\/doi.org\/10.1073\/pnas.1007028107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1511_CR5","doi-asserted-by":"publisher","first-page":"e00491","DOI":"10.1002\/mbo3.491","volume":"6","author":"T Bo","year":"2017","unstructured":"Bo T et al (2017) Relative variations of gut microbiota in disordered cholesterol metabolism caused by high-cholesterol diet and host genetics. Microbiol Open 6(4):e00491. https:\/\/doi.org\/10.1002\/mbo3.491","journal-title":"Microbiol Open"},{"issue":"11","key":"1511_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/ng.3663","volume":"48","author":"MJ Bonder","year":"2016","unstructured":"Bonder MJ et al (2016) The effect of host genetics on the gut microbiome. Nat Genet 48(11):1407\u20131412. https:\/\/doi.org\/10.1038\/ng.3663","journal-title":"Nat Genet"},{"key":"1511_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01121","author":"M Bourgin","year":"2020","unstructured":"Bourgin M et al (2020) Exploring the bacterial impact on cholesterol cycle: a numerical study. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2020.01121","journal-title":"Front Microbiol"},{"issue":"6","key":"1511_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/microorganisms9061122","volume":"9","author":"M Bourgin","year":"2021","unstructured":"Bourgin M et al (2021) Bile salt hydrolases: at the crossroads of microbiota and human health. Microorganisms 9(6):1122. https:\/\/doi.org\/10.3390\/microorganisms9061122","journal-title":"Microorganisms"},{"key":"1511_CR9","doi-asserted-by":"crossref","unstructured":"Briand F et al. (2019) Saccharomyces boulardii CNCM I-745 changes lipidemic profile and gut microbiota in a hamster hypercholesterolemic model - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/31090460\/ (Accessed: 21 September 2025)","DOI":"10.3920\/BM2018.0134"},{"key":"1511_CR10","doi-asserted-by":"publisher","unstructured":"Bridgeman S et al. (2022) Butyrate lowers cellular cholesterol through HDAC inhibition and impaired SREBP-2 signalling. Int J Mol Sci 23(24). https:\/\/doi.org\/10.3390\/ijms232415506","DOI":"10.3390\/ijms232415506"},{"key":"1511_CR11","doi-asserted-by":"crossref","unstructured":"Bulut S, Kabaran S (2025) Effects of probiotic supplementation on blood lipids \u0131n hypercholesterolemic obese patients: a randomized, double-blind, placebo-controlled pilot trial - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/40066582\/ (Accessed: 21 September 2025)","DOI":"10.20960\/nh.05563"},{"issue":"3","key":"1511_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1194\/jlr.M065847","volume":"57","author":"R Caesar","year":"2016","unstructured":"Caesar R et al (2016) Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. J Lipid Res 57(3):474\u2013481. https:\/\/doi.org\/10.1194\/jlr.M065847","journal-title":"J Lipid Res"},{"key":"1511_CR13","doi-asserted-by":"publisher","first-page":"1073113","DOI":"10.3389\/fcimb.2022.1073113","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J et al (2022) Gut microbiota signature as predictors of adverse outcomes after acute ischemic stroke in patients with hyperlipidemia. Front Cell Infect Microbiol 12:1073113. https:\/\/doi.org\/10.3389\/fcimb.2022.1073113","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"1511_CR14","doi-asserted-by":"publisher","first-page":"103964","DOI":"10.1016\/j.numecd.2025.103964","volume":"35","author":"B Chen","year":"2025","unstructured":"Chen B et al (2025) Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: a randomized controlled trial. Nutr Metab Cardiovasc Dis 35(8):103964. https:\/\/doi.org\/10.1016\/j.numecd.2025.103964","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-017-0170-x","volume":"14","author":"LG Dimova","year":"2017","unstructured":"Dimova LG et al (2017) High-cholesterol diet does not alter gut microbiota composition in mice. Nutr Metab 14:15. https:\/\/doi.org\/10.1186\/s12986-017-0170-x","journal-title":"Nutr Metab"},{"key":"1511_CR16","doi-asserted-by":"publisher","first-page":"1513541","DOI":"10.3389\/fmicb.2025.1513541","volume":"16","author":"Z Dong","year":"2025","unstructured":"Dong Z et al (2025) New insights into microbial bile salt hydrolases: from physiological roles to potential applications. Front Microbiol 16:1513541. https:\/\/doi.org\/10.3389\/fmicb.2025.1513541","journal-title":"Front Microbiol"},{"key":"1511_CR17","unstructured":"Flaig B et al. (2023) Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/36615885\/ (Accessed: 8 September 2025)"},{"issue":"2","key":"1511_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MOL.0000000000001027","volume":"37","author":"T Freiberger","year":"2026","unstructured":"Freiberger T (2026) Update on genetics of familial hypercholesterolemia. Curr Opin Lipidol 37(2):38\u201344. https:\/\/doi.org\/10.1097\/MOL.0000000000001027","journal-title":"Curr Opin Lipidol"},{"key":"1511_CR19","unstructured":"Fu J et al. (2015) The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids - PMC. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4596485\/ (Accessed: 25 August 2025)"},{"issue":"2","key":"1511_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/metabo15020118","volume":"15","author":"C Gao","year":"2025","unstructured":"Gao C et al (2025) The potential role of intestinal microbiota on the intestine-protective and lipid-lowering effects of berberine in zebrafish (Danio rerio) under high-lipid stress. Metabolites 15(2):118. https:\/\/doi.org\/10.3390\/metabo15020118","journal-title":"Metabolites"},{"key":"1511_CR21","doi-asserted-by":"publisher","unstructured":"Gargari G et al. (2018) Evidence of dysbiosis in the intestinal microbial ecosystem of children and adolescents with primary hyperlipidemia and the potential role of regular hazelnut intake. FEMS Microbiol Ecol 94(5). https:\/\/doi.org\/10.1093\/femsec\/fiy045","DOI":"10.1093\/femsec\/fiy045"},{"key":"1511_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-6496(03)00285-X","author":"P Gerard","year":"2004","unstructured":"Gerard P et al (2004) Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion. FEMS Microbiol Ecol. https:\/\/doi.org\/10.1016\/S0168-6496(03)00285-X","journal-title":"FEMS Microbiol Ecol"},{"issue":"4","key":"1511_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","volume":"159","author":"JK Goodrich","year":"2014","unstructured":"Goodrich JK et al (2014) Human genetics shape the gut microbiome. Cell 159(4):789\u2013799. https:\/\/doi.org\/10.1016\/j.cell.2014.09.053","journal-title":"Cell"},{"key":"1511_CR24","doi-asserted-by":"publisher","unstructured":"Goodrich JK et al. (2016) Genetic determinants of the gut microbiome in UK Twins. Cell Host Microbe 19(5). https:\/\/doi.org\/10.1016\/j.chom.2016.04.017","DOI":"10.1016\/j.chom.2016.04.017"},{"key":"1511_CR25","unstructured":"Granado-Serrano AB et al. (2019) Faecal bacterial and short-chain fatty acids signature in hypercholesterolemia - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/30742005\/ (Accessed: 21 September 2025)"},{"issue":"4","key":"1511_CR26","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3390\/nu13041206","volume":"13","author":"R Guerrero-Bonmatty","year":"2021","unstructured":"Guerrero-Bonmatty R et al (2021) A combination of Lactoplantibacillus plantarum strains CECT7527, CECT7528, and CECT7529 plus Monacolin K reduces blood cholesterol: results from a randomized, double-blind, placebo-controlled study. Nutrients 13(4):1206. https:\/\/doi.org\/10.3390\/nu13041206","journal-title":"Nutrients"},{"issue":"21","key":"1511_CR27","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1007\/s00253-022-12203-7","volume":"106","author":"Z Guo","year":"2022","unstructured":"Guo Z et al (2022) High fat diet\u2013induced hyperlipidemia and tissue steatosis in rabbits through modulating ileal microbiota. Appl Microbiol Biotechnol 106(21):7187\u20137207. https:\/\/doi.org\/10.1007\/s00253-022-12203-7","journal-title":"Appl Microbiol Biotechnol"},{"issue":"11","key":"1511_CR28","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.3390\/nu12113557","volume":"12","author":"RG Horne","year":"2020","unstructured":"Horne RG et al (2020) High fat-high fructose diet-induced changes in the gut microbiota associated with dyslipidemia in Syrian Hamsters. Nutrients 12(11):3557. https:\/\/doi.org\/10.3390\/nu12113557","journal-title":"Nutrients"},{"key":"1511_CR29","doi-asserted-by":"crossref","unstructured":"Hu L et al. (2024) Role of gut microbiota and metabolomics in the lipid-lowering efficacy of statins among Chinese patients with coronary heart disease and hypercholesterolemia - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/39119290\/ (Accessed: 21 September 2025)","DOI":"10.3389\/fcimb.2024.1408581"},{"issue":"1","key":"1511_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00253-020-10977-2","volume":"105","author":"J Huang","year":"2021","unstructured":"Huang J et al (2021) Supplementation of Bacillus sp. DU-106 reduces hypercholesterolemia and ameliorates gut dysbiosis in high-fat diet rats. Appl Microbiol Biotechnol 105(1):287\u2013299. https:\/\/doi.org\/10.1007\/s00253-020-10977-2","journal-title":"Appl Microbiol Biotechnol"},{"key":"1511_CR31","doi-asserted-by":"publisher","unstructured":"Ja N et al. (2017) The influence of rosuvastatin on the gastrointestinal microbiota and host gene expression profiles. Am J Physiol Gastrointestinal Liver Physiol 312(5). https:\/\/doi.org\/10.1152\/ajpgi.00149.2016","DOI":"10.1152\/ajpgi.00149.2016"},{"issue":"9","key":"1511_CR32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/microorganisms9091881","volume":"9","author":"C Juste","year":"2021","unstructured":"Juste C, G\u00e9rard P (2021) Cholesterol-to-coprostanol conversion by the gut microbiota: what we know, suspect, and ignore. Microorganisms 9(9):1881. https:\/\/doi.org\/10.3390\/microorganisms9091881","journal-title":"Microorganisms"},{"key":"1511_CR33","doi-asserted-by":"publisher","first-page":"106570","DOI":"10.1016\/j.phrs.2022.106570","volume":"187","author":"BA Kappel","year":"2023","unstructured":"Kappel BA et al (2023) Antibiotic-induced gut microbiota depletion exacerbates host hypercholesterolemia. Pharmacol Res 187:106570. https:\/\/doi.org\/10.1016\/j.phrs.2022.106570","journal-title":"Pharmacol Res"},{"issue":"7452","key":"1511_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson FH et al (2013) Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498(7452):99\u2013103. https:\/\/doi.org\/10.1038\/nature12198","journal-title":"Nature"},{"issue":"2","key":"1511_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2020.05.013","volume":"28","author":"DJ Kenny","year":"2020","unstructured":"Kenny DJ et al (2020) Cholesterol metabolism by uncultured human gut bacteria influences host cholesterol level. Cell Host Microbe 28(2):245-257.e6. https:\/\/doi.org\/10.1016\/j.chom.2020.05.013","journal-title":"Cell Host Microbe"},{"issue":"3","key":"1511_CR36","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s12602-023-10191-2","volume":"17","author":"F Kerlikowsky","year":"2025","unstructured":"Kerlikowsky F et al (2025) Distinct microbial taxa are associated with LDL-Cholesterol reduction after 12 weeks of Lactobacillus plantarum intake in mild hypercholesterolemia: results of a randomized controlled study. Probiotics Antimicrob Proteins 17(3):1086\u20131095. https:\/\/doi.org\/10.1007\/s12602-023-10191-2","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"8","key":"1511_CR37","doi-asserted-by":"publisher","first-page":"e3064","DOI":"10.1371\/journal.pone.0003064","volume":"3","author":"ZA Khachatryan","year":"2008","unstructured":"Khachatryan ZA et al (2008) Predominant role of host genetics in controlling the composition of gut microbiota. PLoS ONE 3(8):e3064. https:\/\/doi.org\/10.1371\/journal.pone.0003064","journal-title":"PLoS ONE"},{"issue":"2","key":"1511_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/omi.2017.0130","volume":"22","author":"TJ Khan","year":"2018","unstructured":"Khan TJ, Ahmed YM, Zamzami MA, Siddiqui AM et al (2018a) Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients. Omics: A Journal of Integrative Biology 22(2):154\u2013163. https:\/\/doi.org\/10.1089\/omi.2017.0130","journal-title":"Omics: A Journal of Integrative Biology"},{"issue":"1","key":"1511_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41598-017-19013-2","volume":"8","author":"TJ Khan","year":"2018","unstructured":"Khan TJ, Ahmed YM, Zamzami MA, Mohamed SA et al (2018b) Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats. Sci Rep 8(1):662. https:\/\/doi.org\/10.1038\/s41598-017-19013-2","journal-title":"Sci Rep"},{"issue":"3","key":"1511_CR40","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/nu15030661","volume":"15","author":"J Khongrum","year":"2023","unstructured":"Khongrum J et al (2023) Safety and effects of Lactobacillus paracasei TISTR 2593 supplementation on improving cholesterol metabolism and atherosclerosis-related parameters in subjects with hypercholesterolemia: a randomized, double-blind, placebo-controlled clinical trial. Nutrients 15(3):661. https:\/\/doi.org\/10.3390\/nu15030661","journal-title":"Nutrients"},{"key":"1511_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-014-0107-1","author":"D Knights","year":"2014","unstructured":"Knights D et al (2014) Complex host genetics influence the microbiome in inflammatory bowel disease. Genome Med. https:\/\/doi.org\/10.1186\/s13073-014-0107-1","journal-title":"Genome Med"},{"key":"1511_CR42","doi-asserted-by":"publisher","first-page":"1342388","DOI":"10.3389\/fcvm.2024.1342388","volume":"11","author":"C Langhi","year":"2024","unstructured":"Langhi C et al (2024) A polyphenol-rich plant extract prevents hypercholesterolemia and modulates gut microbiota in western diet-fed mice. Front Cardiovasc Med 11:1342388. https:\/\/doi.org\/10.3389\/fcvm.2024.1342388","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"1511_CR44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.chom.2022.05.002","volume":"30","author":"HH Le","year":"2022","unstructured":"Le HH, Lee M-T et al (2022a) Host hepatic metabolism is modulated by gut microbiota-derived sphingolipids. Cell Host Microbe 30(6):798-808.e7. https:\/\/doi.org\/10.1016\/j.chom.2022.05.002","journal-title":"Cell Host Microbe"},{"issue":"9","key":"1511_CR43","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41564-022-01195-9","volume":"7","author":"HH Le","year":"2022","unstructured":"Le HH, lee M-T et al (2022b) Characterization of interactions of dietary cholesterol with the murine and human gut microbiome. Nat Microbiol 7(9):1390\u20131403. https:\/\/doi.org\/10.1038\/s41564-022-01195-9","journal-title":"Nat Microbiol"},{"issue":"1","key":"1511_CR45","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12915-019-0715-8","volume":"17","author":"T Le Roy","year":"2019","unstructured":"Le Roy T et al (2019) The intestinal microbiota regulates host cholesterol homeostasis. BMC Biol 17(1):94. https:\/\/doi.org\/10.1186\/s12915-019-0715-8","journal-title":"BMC Biol"},{"issue":"24","key":"1511_CR46","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1021\/acs.jafc.1c02532","volume":"69","author":"D Li","year":"2021","unstructured":"Li D et al (2021) Apple polyphenol extract improves high-fat diet-induced hepatic steatosis by regulating bile acid synthesis and gut microbiota in C57BL\/6 male mice. J Agric Food Chem 69(24):6829\u20136841. https:\/\/doi.org\/10.1021\/acs.jafc.1c02532","journal-title":"J Agric Food Chem"},{"issue":"23","key":"1511_CR47","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.3390\/nu14234945","volume":"14","author":"X Li","year":"2022","unstructured":"Li X et al (2022) Lactobacillus gasseri RW2014 ameliorates hyperlipidemia by modulating bile acid metabolism and gut microbiota composition in rats. Nutrients 14(23):4945. https:\/\/doi.org\/10.3390\/nu14234945","journal-title":"Nutrients"},{"issue":"8","key":"1511_CR48","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","volume":"187","author":"C Li","year":"2024","unstructured":"Li C et al (2024) Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell 187(8):1834-1852.e19. https:\/\/doi.org\/10.1016\/j.cell.2024.03.014","journal-title":"Cell"},{"key":"1511_CR49","doi-asserted-by":"publisher","unstructured":"Li B et al. (2025) Enhanced efficacy of low-dose lovastatin through probiotic-mediated absorption: insights from In Vitro and In Vivo Studies. Engineering [Preprint]. https:\/\/doi.org\/10.1016\/j.eng.2025.04.017","DOI":"10.1016\/j.eng.2025.04.017"},{"issue":"1","key":"1511_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1538\/expanim.20-0094","volume":"70","author":"H Liang","year":"2021","unstructured":"Liang H et al (2021) A high-fat diet and high-fat and high-cholesterol diet may affect glucose and lipid metabolism differentially through gut microbiota in mice. Exp Anim 70(1):73\u201383. https:\/\/doi.org\/10.1538\/expanim.20-0094","journal-title":"Exp Anim"},{"issue":"1","key":"1511_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41522-022-00287-y","volume":"8","author":"RRX Lim","year":"2022","unstructured":"Lim RRX et al (2022) Gut microbiome responses to dietary intervention with hypocholesterolemic vegetable oils. Npj Biofilms Microbiomes 8(1):24. https:\/\/doi.org\/10.1038\/s41522-022-00287-y","journal-title":"Npj Biofilms Microbiomes"},{"key":"1511_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-018-0811-8","author":"B Liu","year":"2018","unstructured":"Liu B, Zhang Y, Liu E (2018) Western diet feeding influences gut microbiota profiles in apoE knockout mice. Lipids Health Dis. https:\/\/doi.org\/10.1186\/s12944-018-0811-8","journal-title":"Lipids Health Dis"},{"key":"1511_CR53","doi-asserted-by":"publisher","first-page":"605954","DOI":"10.3389\/fcimb.2021.605954","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H et al (2021) A comprehensive analysis of genomics and metagenomics in a heterozygote familial hypercholesterolemia family. Front Cell Infect Microbiol 11:605954. https:\/\/doi.org\/10.3389\/fcimb.2021.605954","journal-title":"Front Cell Infect Microbiol"},{"key":"1511_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s43587-024-00590-7","author":"Y Liu","year":"2024","unstructured":"Liu Y et al (2024) Integration of polygenic and gut metagenomic risk prediction for common diseases. Nat Aging. https:\/\/doi.org\/10.1038\/s43587-024-00590-7","journal-title":"Nat Aging"},{"issue":"3","key":"1511_CR55","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1080\/10408398.2023.2276883","volume":"65","author":"Y Liu","year":"2025","unstructured":"Liu Y et al (2025a) Interactions between dietary cholesterol and intestinal flora and their effects on host health. Crit Rev Food Sci Nutr 65(3):494\u2013506. https:\/\/doi.org\/10.1080\/10408398.2023.2276883","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"18","key":"1511_CR56","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.3390\/nu17183019","volume":"17","author":"Y Liu","year":"2025","unstructured":"Liu Y et al (2025b) Cholesterol-lowering mechanism of Lactobacillus bile salt hydrolase through regulation of Bifidobacterium pseudolongum in the gut microbiota. Nutrients 17(18):3019. https:\/\/doi.org\/10.3390\/nu17183019","journal-title":"Nutrients"},{"key":"1511_CR57","doi-asserted-by":"crossref","unstructured":"Lv W-J et al. (2023) Phytosterols Alleviate Hyperlipidemia by Regulating Gut Microbiota and Cholesterol Metabolism in Mice - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/37151603\/ (Accessed: 21 September 2025)","DOI":"10.1155\/2023\/6409385"},{"issue":"1","key":"1511_CR58","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","volume":"14","author":"JB Lynch","year":"2023","unstructured":"Lynch JB et al (2023) Gut microbiota Turicibacter strains differentially modify bile acids and host lipids. Nat Commun 14(1):3669. https:\/\/doi.org\/10.1038\/s41467-023-39403-7","journal-title":"Nat Commun"},{"key":"1511_CR59","unstructured":"Martin K, Ole Geir S, Christopher S-L (2020) Rosuvastatin alters the genetic composition of the human gut microbiome - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/32214138\/ (Accessed: 8 September 2025)"},{"issue":"6","key":"1511_CR60","doi-asserted-by":"publisher","first-page":"e39191","DOI":"10.1371\/journal.pone.0039191","volume":"7","author":"AM McKnite","year":"2012","unstructured":"McKnite AM et al (2012) Murine gut microbiota is defined by host genetics and modulates variation of metabolic traits. PLoS One 7(6):e39191. https:\/\/doi.org\/10.1371\/journal.pone.0039191","journal-title":"PLoS One"},{"key":"1511_CR61","doi-asserted-by":"publisher","first-page":"943609","DOI":"10.3389\/fcimb.2022.943609","volume":"12","author":"C Morales","year":"2022","unstructured":"Morales C et al (2022) Characterization of microbial communities from gut microbiota of hypercholesterolemic and control subjects. Front Cell Infect Microbiol 12:943609. https:\/\/doi.org\/10.3389\/fcimb.2022.943609","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"1511_CR62","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.3390\/ijms24087213","volume":"24","author":"C Morales","year":"2023","unstructured":"Morales C et al (2023) Differences in bacterial small RNAs in stool samples from hypercholesterolemic and normocholesterolemic subjects. Int J Mol Sci 24(8):7213. https:\/\/doi.org\/10.3390\/ijms24087213","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1511_CR63","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1039\/c5fo00886g","volume":"7","author":"I Moreno-Indias","year":"2016","unstructured":"Moreno-Indias I et al (2016) Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients. Food Funct 7(4):1775\u20131787. https:\/\/doi.org\/10.1039\/c5fo00886g","journal-title":"Food Funct"},{"issue":"1","key":"1511_CR64","doi-asserted-by":"publisher","first-page":"e70997","DOI":"10.1111\/jcmm.70997","volume":"30","author":"WB Ncir","year":"2026","unstructured":"Ncir WB et al (2026) First LDLRAP1 and recurrent LDLR mutations in Tunisian families with familial hypercholesterolemia. J Cell Mol Med 30(1):e70997. https:\/\/doi.org\/10.1111\/jcmm.70997","journal-title":"J Cell Mol Med"},{"issue":"17","key":"1511_CR65","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.3390\/nu16172916","volume":"16","author":"K Nuankham","year":"2024","unstructured":"Nuankham K et al (2024) Impact of Lactocaseibacillus (Lactobacillus) paracasei sup. paracasei TISTR 2593 probiotic supplementation on the gut microbiome of hypercholesterolemia patients: A randomized controlled trial. Nutrients 16(17):2916. https:\/\/doi.org\/10.3390\/nu16172916","journal-title":"Nutrients"},{"issue":"10","key":"1511_CR66","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1101\/gr.194118.115","volume":"25","author":"E Org","year":"2015","unstructured":"Org E et al (2015) Genetic and environmental control of host-gut microbiota interactions. Genome Res 25(10):1558\u20131569. https:\/\/doi.org\/10.1101\/gr.194118.115","journal-title":"Genome Res"},{"key":"1511_CR67","doi-asserted-by":"publisher","unstructured":"ResearchGate (no date) (n.d.) (PDF) Cholesterol-lowering effect of bile salt hydrolase from a Lactobacillus johnsonii strain mediated by FXR pathway regulation. https:\/\/doi.org\/10.1039\/D1FO03143K","DOI":"10.1039\/D1FO03143K"},{"key":"1511_CR68","doi-asserted-by":"crossref","unstructured":"Roessler J, Zimmermann F, Schmidt D (2020) Impact of the gut microbiome on the atorvastatin-dependent modulation of the serum lipidome | European Heart Journal | Oxford Academic. Available at: https:\/\/academic.oup.com\/eurheartj\/article\/41\/Supplement_2\/ehaa946.3823\/6005860 (Accessed: 21 September 2025)","DOI":"10.1093\/ehjci\/ehaa946.3823"},{"issue":"4","key":"1511_CR69","doi-asserted-by":"publisher","first-page":"e13927","DOI":"10.1111\/eci.13927","volume":"53","author":"L Schoch","year":"2023","unstructured":"Schoch L et al (2023) The gut microbiome dysbiosis is recovered by restoring a normal diet in hypercholesterolemic pigs. Eur J Clin Invest 53(4):e13927. https:\/\/doi.org\/10.1111\/eci.13927","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"1511_CR70","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/00365513.2022.2102540","volume":"82","author":"C Storm-Larsen","year":"2022","unstructured":"Storm-Larsen C et al (2022) Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial. Scand J Clin Lab Invest 82(5):363\u2013370. https:\/\/doi.org\/10.1080\/00365513.2022.2102540","journal-title":"Scand J Clin Lab Invest"},{"issue":"12","key":"1511_CR71","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s12275-018-8152-x","volume":"56","author":"B Sun","year":"2018","unstructured":"Sun B, Li L, Zhou X (2018) Comparative analysis of the gut microbiota in distinct statin response patients in East China. J Microbiol 56(12):886\u2013892. https:\/\/doi.org\/10.1007\/s12275-018-8152-x","journal-title":"J Microbiol"},{"issue":"11","key":"1511_CR72","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1038\/ismej.2014.64","volume":"8","author":"M Tong","year":"2014","unstructured":"Tong M et al (2014) Reprograming of gut microbiome energy metabolism by the FUT2 Crohn\u2019s disease risk polymorphism. ISME J 8(11):2193\u20132206. https:\/\/doi.org\/10.1038\/ismej.2014.64","journal-title":"ISME J"},{"issue":"3","key":"1511_CR73","doi-asserted-by":"publisher","first-page":"e0444022","DOI":"10.1128\/spectrum.04440-22","volume":"11","author":"H Wang","year":"2023","unstructured":"Wang H et al (2023) Probio-X relieves symptoms of hyperlipidemia by regulating patients\u2019 gut microbiome, blood lipid metabolism, and lifestyle habits. Microbiol Spectr 11(3):e0444022. https:\/\/doi.org\/10.1128\/spectrum.04440-22","journal-title":"Microbiol Spectr"},{"key":"1511_CR74","doi-asserted-by":"publisher","unstructured":"Wilmanski T et al. (2022) Heterogeneity in statin responses explained by variation in the human gut microbiome. Med (New York, N.Y.) 3(6). https:\/\/doi.org\/10.1016\/j.medj.2022.04.007","DOI":"10.1016\/j.medj.2022.04.007"},{"key":"1511_CR75","doi-asserted-by":"publisher","unstructured":"Wu C et al. (2021) Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR\u2019s cholesterol-decreasing efficacy in patients. J Adv Rese 37. https:\/\/doi.org\/10.1016\/j.jare.2021.07.011","DOI":"10.1016\/j.jare.2021.07.011"},{"key":"1511_CR76","unstructured":"Xiaomin H et al. (2021) Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome - PubMed. Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/33897881\/ (Accessed: 8 September 2025)"},{"issue":"3","key":"1511_CR77","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/jsfa.12222","volume":"103","author":"W Xu","year":"2023","unstructured":"Xu W et al (2023) L-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism. J Sci Food Agric 103(3):1283\u20131293. https:\/\/doi.org\/10.1002\/jsfa.12222","journal-title":"J Sci Food Agric"},{"key":"1511_CR78","doi-asserted-by":"publisher","unstructured":"Xu H et al. (2023) Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Microbiome 11(1). https:\/\/doi.org\/10.1186\/s40168-023-01709-5","DOI":"10.1186\/s40168-023-01709-5"},{"key":"1511_CR79","doi-asserted-by":"publisher","first-page":"113749","DOI":"10.1016\/j.biopha.2022.113749","volume":"155","author":"Y-N Yang","year":"2022","unstructured":"Yang Y-N et al (2022) The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Biomed Pharmacother 155:113749. https:\/\/doi.org\/10.1016\/j.biopha.2022.113749","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1511_CR80","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41522-023-00383-7","volume":"9","author":"X Yang","year":"2023","unstructured":"Yang X et al (2023) Ecological change of the gut microbiota during pregnancy and progression to dyslipidemia. Npj Biofilms Microbiomes 9(1):14. https:\/\/doi.org\/10.1038\/s41522-023-00383-7","journal-title":"Npj Biofilms Microbiomes"},{"key":"1511_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00530","author":"L Yinhui","year":"2018","unstructured":"Yinhui L et al (2018) Gut microbiome associates with lipid-lowering effect of rosuvastatin in vivo. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.00530","journal-title":"Front Microbiol"},{"key":"1511_CR82","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fphar.2020.00522","volume":"11","author":"Q Zhang","year":"2020","unstructured":"Zhang Q et al (2020a) The effect of simvastatin on gut microbiota and lipid metabolism in hyperlipidemic rats induced by a high-fat diet. Front Pharmacol 11:522. https:\/\/doi.org\/10.3389\/fphar.2020.00522","journal-title":"Front Pharmacol"},{"issue":"5","key":"1511_CR83","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3892\/ijmm.2020.4516","volume":"45","author":"S Zhang","year":"2020","unstructured":"Zhang S et al (2020b) Molecular characterization of gut microbiota in high\u2011lipid diet\u2011induced hyperlipidemic rats treated with simvastatin. Int J Mol Med 45(5):1601\u20131615. https:\/\/doi.org\/10.3892\/ijmm.2020.4516","journal-title":"Int J Mol Med"},{"issue":"3","key":"1511_CR84","doi-asserted-by":"publisher","first-page":"e0230200","DOI":"10.1371\/journal.pone.0230200","volume":"15","author":"C Zhao","year":"2020","unstructured":"Zhao C et al (2020) An in vitro evaluation of the effects of different statins on the structure and function of human gut bacterial community. PLoS One 15(3):e0230200. https:\/\/doi.org\/10.1371\/journal.pone.0230200","journal-title":"PLoS One"},{"issue":"11","key":"1511_CR85","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.3390\/nu15112600","volume":"15","author":"K Zhao","year":"2023","unstructured":"Zhao K et al (2023) Alleviation syndrome of high-cholesterol-diet-induced hypercholesterolemia in mice by intervention with Lactiplantibacillus plantarum WLPL21 via regulation of cholesterol metabolism and transportation as well as gut microbiota. Nutrients 15(11):2600. https:\/\/doi.org\/10.3390\/nu15112600","journal-title":"Nutrients"},{"issue":"7996","key":"1511_CR86","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41586-023-06893-w","volume":"625","author":"DV Zhernakova","year":"2024","unstructured":"Zhernakova DV et al (2024) Host genetic regulation of human gut microbial structural variation. Nature 625(7996):813\u2013821. https:\/\/doi.org\/10.1038\/s41586-023-06893-w","journal-title":"Nature"},{"issue":"20","key":"1511_CR87","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.3390\/nu15204445","volume":"15","author":"X Zhou","year":"2023","unstructured":"Zhou X et al (2023) Causal associations between gut microbiota and different types of dyslipidemia: a two-sample mendelian randomization study. Nutrients 15(20):4445. https:\/\/doi.org\/10.3390\/nu15204445","journal-title":"Nutrients"},{"issue":"7","key":"1511_CR88","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1007\/s00253-019-09681-7","volume":"103","author":"Y Zhu","year":"2019","unstructured":"Zhu Y et al (2019) Beneficial effects of Enterococcus faecalis in hypercholesterolemic mice on cholesterol transportation and gut microbiota. Appl Microbiol Biotechnol 103(7):3181\u20133191. https:\/\/doi.org\/10.1007\/s00253-019-09681-7","journal-title":"Appl Microbiol Biotechnol"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01511-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:02:20Z","timestamp":1780470140000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01511-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":88,"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01511-4","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}